More about

Thyroid Cancer

News
March 10, 2023
2 min read
Save

History of thyroid cancer not linked to reduced pregnancy rate for women

History of thyroid cancer not linked to reduced pregnancy rate for women

Women who were diagnosed with thyroid cancer as adolescents or young adults have no difference in pregnancy rates compared with those who have never had thyroid cancer, according to a study published in Thyroid.

News
December 29, 2022
2 min read
Save

Top 2022 thyroid news: Cancer rates, thyroid hormones and NAFLD, and more

Top 2022 thyroid news: Cancer rates, thyroid hormones and NAFLD, and more

The Healio and Endocrine Today editors have compiled the top thyroid news stories from 2022.

News
December 28, 2022
2 min read
Save

Head and neck cancer 2022: New standards, active surveillance and second malignancy risk

Head and neck cancer 2022: New standards, active surveillance and second malignancy risk

Research in 2022 spotlighted several innovative and potentially effective treatment regimens for head and neck cancer.

News
December 20, 2022
2 min read
Save

Cancer history does not affect survival odds for adults with anaplastic thyroid carcinoma

Cancer history does not affect survival odds for adults with anaplastic thyroid carcinoma

Overall survival rates for adults diagnosed with anaplastic thyroid carcinoma are similar between those with a history of cancer and those with no previous cancer diagnosis, according to findings published in Thyroid.

News
December 14, 2022
1 min read
Save

Top in endocrinology: Thyroid cancer risk; time-restricted eating

Top in endocrinology: Thyroid cancer risk; time-restricted eating

A recent study found that patients with type 2 diabetes who used a GLP-1 receptor agonist for more than 1 year had an increased risk for thyroid cancer compared with non-users.

News
December 06, 2022
2 min read
Save

GLP-1 receptor agonist use for more than 1 year may increase thyroid cancer risk

GLP-1 receptor agonist use for more than 1 year may increase thyroid cancer risk

Adults with type 2 diabetes who use a GLP-1 receptor agonist for more than 1 year may have an increased risk for thyroid cancer, according to findings published in Diabetes Care.

News
November 30, 2022
2 min watch
Save

VIDEO: New data on medullary thyroid cancer at American Thyroid Association Annual Meeting

VIDEO: New data on medullary thyroid cancer at American Thyroid Association Annual Meeting

In this video, Maria E. Cabanillas, MD, an oncologic endocrinologist at The University of Texas MD Anderson Cancer Center, discussed an update to the ARROW study.

News
November 29, 2022
1 min read
Save

Immunotherapy added to BRAF/MEK inhibitor improves OS for anaplastic thyroid cancer

The triplet combination of vemurafenib/cobimetinib/atezolizumab showed improvement in overall survival in patients with BRAF-mutated anaplastic thyroid cancer, according to research presented at American Thyroid Association Annual Meeting.

News
November 29, 2022
2 min watch
Save

VIDEO: 'Verdict still out' for mono vs. combo therapy for differentiated thyroid cancer

VIDEO: 'Verdict still out' for mono vs. combo therapy for differentiated thyroid cancer

In this video, Maria E. Cabanillas, MD, an oncologic endocrinologist at The University of Texas MD Anderson Cancer Center, discussed important research on immunotherapy combinations presented at American Thyroid Association Annual Meeting.

News
November 15, 2022
4 min watch
Save

VIDEO: Molecular tests may provide valuable prognostic information for thyroid cancer

VIDEO: Molecular tests may provide valuable prognostic information for thyroid cancer

In this video, John M. Skaugen, MD, an assistant professor of pathology at University of Pittsburgh discusses his study presented at the American Thyroid Association 2022 annual meeting.

View more